Inflammatory Bowel Disease and Atherosclerosis Development

NCT05781737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2026-05-12

No results posted yet for this study

Summary

The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis

Conditions

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-01-30
Completion
2025-01-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05781737 on ClinicalTrials.gov